[1]
C. L. G. Lopes et al., “COMPARATIVE EFFICACY BETWEEN LONG-ACTING BETA-2 AGONISTS (LABA) AND LONG-ACTING MUSCARINIC ANTAGONISTS (LAMA) IN THE CLINICAL RESPONSE OF DPOC PATIENTS: A SYSTEMATIC REVIEW”, REASE, vol. 12, no. 6, pp. 1–22, Jun. 2026, doi: 10.51891/rease.v12i6.27701.